Mr. Hadyn Parry (Oxitec) is CEO of Oxitec, a British biotech company developing innovative new solutions to controlling insects that spread disease and damage crops. In particular, Oxitec is pioneering a better approach to tackling dengue fever and damaging agricultural pests.
Hadyn Parry has an extensive background in the Life Science sector. During his fifteen-year career at Zeneca he held various positions, including General Manager of Zeneca Plant Sciences and European Director and Global Head of R&D for Advanta, one of the world’s largest seed companies. More recently he was CEO of MNL Pharmaceuticals, a company that was focused on pioneering a novel approach in immunology.
Hadyn is also Chairman of Help For Heroes, a charity founded in 2007 to support wounded British servicemen and women.